Fatty liver disease subgroups

The background

There is a recent publication: The Effect of Liv.52 DS in Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD): A Pilot, Randomized, Double-Blind, Placebo-Controlled, Clinical Study

The publication is available via NIH.

The challenge

Create visualisation to explore possible differences in the treatment effect with regard to subgroups.

The data

The data is derived to match the plotted results in the publication. Some baseline characteristics are simulated for the purpose of the challenge.

Variable Name	Variable Label
Group	Treatment group
Baseline_kPa	Baseline value of the LSM Score
EOS_kPa	End of study value of the LSM Score
Sex	Sex (male/female)
Steatosis	Course of steatosis
Age	Age at baseline in years
Weight	Baseline weight in kg